rs5742909, CTLA4

N. diseases: 40
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Rheumatoid Arthritis
CUI: C0003873
Disease: Rheumatoid Arthritis
2387 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.030 0.667 3 2013 2017
Ewings sarcoma
CUI: C0553580
Disease: Ewings sarcoma
25 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.020 1.000 2 2012 2013
Graves Disease
CUI: C0018213
Disease: Graves Disease
352 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.020 1.000 2 2016 2017
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
347 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.020 1.000 2 2015 2019
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
1641 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.020 1.000 2 2015 2018
Primary biliary cirrhosis
CUI: C0008312
Disease: Primary biliary cirrhosis
667 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.020 1.000 2 2010 2017
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
1374 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.020 1.000 2 2015 2018
Anemia, Sickle Cell
CUI: C0002895
Disease: Anemia, Sickle Cell
138 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2019 2019
Brucellosis
CUI: C0006309
Disease: Brucellosis
30 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2014 2014
cervical cancer
CUI: C4048328
Disease: cervical cancer
268 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2014 2014
Cervix carcinoma
CUI: C0302592
Disease: Cervix carcinoma
283 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2014 2014
Childhood Osteosarcoma
CUI: C1332986
Disease: Childhood Osteosarcoma
151 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2011 2011
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
194 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2014 2014
Chronic Obstructive Airway Disease
CUI: C0024117
Disease: Chronic Obstructive Airway Disease
852 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2010 2010
Diabetes Mellitus, Insulin-Dependent
954 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2019 2019
Diabetes Mellitus, Non-Insulin-Dependent
2672 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2019 2019
Drug-Induced Liver Disease
CUI: C0860207
Disease: Drug-Induced Liver Disease
29 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2012 2012
Focal glomerulosclerosis
CUI: C0017668
Disease: Focal glomerulosclerosis
50 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2019 2019
Hashimoto Disease
CUI: C0677607
Disease: Hashimoto Disease
131 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2016 2016
Idiopathic Nephrotic Syndrome
CUI: C3496337
Disease: Idiopathic Nephrotic Syndrome
72 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2019 2019
Infantile nystagmus syndrome
CUI: C1533172
Disease: Infantile nystagmus syndrome
8 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1 2019 2019
Kidney Failure, Chronic
CUI: C0022661
Disease: Kidney Failure, Chronic
425 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2014 2014
Latent Autoimmune Diabetes in Adults
12 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2009 2009
Latent autoimmune diabetes mellitus in adult
12 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2009 2009
Lipoid nephrosis
CUI: C0027721
Disease: Lipoid nephrosis
3 0.614 0.680 2 203867624 upstream gene variant C/T snv 6.7E-02 0.010 1.000 1 2019 2019